Salud financiera de hoja de balance de Thermo Fisher Scientific
Salud financiera controles de criterios 3/6
Thermo Fisher Scientific tiene un patrimonio de accionistas total de $49.1B y una deuda total de $35.3B, lo que sitúa su ratio deuda-patrimonio en 71.9%. Sus activos y pasivos totales son $100.4B y $51.3B respectivamente. El BAIT de Thermo Fisher Scientific es de $7.4B, por lo que su ratio de cobertura de intereses es de 24.4. Tiene efectivo e inversiones a corto plazo que ascienden a $6.6B.
Información clave
71.9%
Ratio deuda-patrimonio
US$35.31b
Deuda
| Ratio de cobertura de intereses | 24.4x |
| Efectivo | US$6.65b |
| Patrimonio | US$49.10b |
| Total pasivo | US$51.27b |
| Activos totales | US$100.36b |
Actualizaciones recientes sobre salud financiera
These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well
Sep 21
Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?
Jun 18We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt
Mar 12Recent updates
Thermo Fisher Scientific: Near The Bottom And Attractively Valued
Nov 14Thermo Fisher Scientific Q3: Expecting Market Recovery In FY25; Upgrade To 'Buy'
Oct 23Thermo Fisher Scientific: Fantastic Company, Rich Valuation
Oct 04These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well
Sep 21Thermo Fisher Scientific Inc.'s (NYSE:TMO) Price Is Out Of Tune With Earnings
Aug 16Thermo Fisher Scientific: Microscopic Signs Of Growth Emerging
Jul 25A Look At The Fair Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)
Jul 11Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?
Jun 18Low Yield, High Growth: Unveiling The Power Of Thermo Fisher's Dividends
Jun 07Thermo Fisher: Renewed Growth Yet To Materialize, But Already Priced In (Rating Downgrade)
Apr 30Thermo Fisher Scientific Inc. (NYSE:TMO) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Apr 27Why Thermo Fisher Scientific Inc. (NYSE:TMO) Could Be Worth Watching
Apr 24Thermo Fisher Scientific: Too Hot To Handle
Apr 15Investors Still Waiting For A Pull Back In Thermo Fisher Scientific Inc. (NYSE:TMO)
Apr 02We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt
Mar 12Thermo Fisher's Bright Future Makes It A Great Buy On Weakness
Feb 06Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results
Feb 02Thermo Fisher: Blue Chip Stock Melded With Growth Characteristics
Jan 16Thermo Fisher: Downturn In Pharma And Biotech And Weak China Growth; Initiate With 'Hold'
Jan 06Is Now An Opportune Moment To Examine Thermo Fisher Scientific Inc. (NYSE:TMO)?
Dec 29Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($23.8B) de TMO superan a sus pasivos a corto plazo ($14.6B).
Pasivo a largo plazo: Los activos a corto plazo ($23.8B) de TMO no cubren sus pasivos a largo plazo ($36.7B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de TMO (58.4%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de TMO ha crecido de 58.2% a 71.9% en los últimos 5 años.
Cobertura de la deuda: La deuda de TMO está bien cubierta por el flujo de caja operativo (25.8%).
Cobertura de intereses: Los pagos de intereses de la deuda de TMO están bien cubiertos por el BAIT (24.4x cobertura).